Study of Hormonal Sideeffects in Patients Taking Levetiracetam, Carbamazepine or Lamotrigine for Epilepsy
NCT00460070 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 240
Last updated 2011-07-27
Summary
Some antiepileptic drugs are found to have hormonal side effects. We want to study possible hormonal side effects of the relatively new antiepileptic drug; levetiracetam and compare it to the older drugs; lamotrigine and carbamazepine. The participants are going to fill in a questionnaire and we will collect blood samples from them, to analyse hormones.
Conditions
Sponsors & Collaborators
- collaborator INDUSTRY
-
Rikshospitalet University Hospital
lead OTHER
Principal Investigators
-
Erik Taubøll, MD · unaffiliation
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-01-31
- Completion
- 2009-03-31
Countries
- Norway
Study Locations
More Related Trials
-
Effect of Levetiracetam on Brain Excitability
NCT00006191 ·Status: COMPLETED
-
Evaluate Retention Rate of Topiramate, Levetiracetam and Oxcarbazepine in a Long-term Epilepsy Treatment
NCT02098941 ·Status: UNKNOWN
-
Seizure Prevention in Traumatic Brain Injury With Levetiracetam and Lacosamide
NCT06866691 ·Status: RECRUITING ·Phase: PHASE4
-
Monotherapy With Levetiracetam in Patients Suffering From Epilepsy.
NCT00150813 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Valproate Versus Levetiracetam Monotherapy on Reproductive Functions in Epileptic Males
NCT03953781 ·Status: COMPLETED
-
Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subjects With Newly or Recently Diagnosed Partial Epilepsy
NCT01498822 ·Status: COMPLETED ·Phase: PHASE4
-
Monotherapy With Levetiracetam in Newly Diagnosed Patients Suffering From Epilepsy
NCT00150735 ·Status: COMPLETED ·Phase: PHASE3
-
Prevention of Post-traumatic Seizures With Levetiracetam
NCT00566046 ·Status: TERMINATED ·Phase: PHASE3
-
Cognitive Effects of Treatment of Interictal Discharges
NCT00916149 ·Status: COMPLETED ·Phase: NA
-
Study on the Treatment of Elderly Patients With Older and Newer Antiepileptic Drugs
NCT00438451 ·Status: COMPLETED ·Phase: PHASE4
-
Levetiracetam Versus Standard Antiepileptic Drugs (Carbamazepine and Valproate) Used as Monotherapy in Patients With Newly Diagnosed Epilepsy
NCT00175903 ·Status: COMPLETED ·Phase: PHASE3
-
Does Levetiracetam and Carbamazepine Impact the Autonomic Activity of Children With Self-limiting Focal Epilepsy?
NCT06138847 ·Status: ACTIVE_NOT_RECRUITING
-
Long Term Follow-up Study With Keppra XR (Levetiracetam XR) for Partial Seizures
NCT00419393 ·Status: COMPLETED ·Phase: PHASE3
-
Levetiracetam: The Anti-Convulsant of Choice for Elderly Patients With Dementia
NCT01318408 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetic and Placental Transfer of Levetiracetam
NCT04117425 ·Status: UNKNOWN ·Phase: NA
-
Safety and Tolerability Study of Levetiracetam to Treat Patients With Status Epilepticus
NCT00362141 ·Status: UNKNOWN ·Phase: PHASE2
-
Open-label, Randomized, Active-controlled Study of LEV Used as Monotherapy in Patients With Partial-Onset Seizures
NCT01954121 ·Status: COMPLETED ·Phase: PHASE3
-
Levetiracetam Versus Carbamazepine in Post-Stroke Late Onset Crisis
NCT00542802 ·Status: UNKNOWN ·Phase: PHASE3
-
A Long Term Follow up Administration Study of L059 (Levetiracetam) in Epilepsy Patients With Partial Onset Seizures
NCT00367432 ·Status: COMPLETED ·Phase: PHASE3
-
Pregabalin Versus Levetiracetam In Partial Seizures
NCT00537238 ·Status: COMPLETED ·Phase: PHASE3
-
Long Term Follow up Treatment With Levetiracetam in Subjects of 4 Years and Older With Generalized Epilepsy
NCT00150748 ·Status: COMPLETED ·Phase: PHASE3
-
The GABAergic Inhibitory System in Drug Resistant Epilepsy
NCT06789497 ·Status: COMPLETED ·Phase: NA
-
Levetiracetam in Treating Patients With Seizures Caused by Brain Metastases
NCT00415376 ·Status: WITHDRAWN ·Phase: NA
-
An Open Label Study of Levetiracetam Monotherapy in Patients With Newly Diagnosed Focal Epilepsy
NCT01506882 ·Status: COMPLETED ·Phase: PHASE3
-
1 Week Versus 6 Weeks of Levetiracetam in Surgical Brain Tumor Patients
NCT02334722 ·Status: COMPLETED ·Phase: PHASE4